GSK's Flonase Allergy Relief reaches £110mn

4 August 2015 - Deborah Wilkes

Archived

GlaxoSmithKline said Flonase Allergy Relief had recorded sales of £45 million (US$70 million) in the second quarter of 2015, following the recent switch to OTC status in the US. The nasal spray containing fluticasone propionate has generated sales of £110 million since its launch in the US in early 2015.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: